NM_000321.3:c.1695+3A>C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_000321.3(RB1):c.1695+3A>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000321.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1695+3A>C | splice_region_variant, intron_variant | Intron 17 of 26 | ENST00000267163.6 | NP_000312.2 | ||
RB1 | NM_001407166.1 | c.1698A>C | p.Val566Val | synonymous_variant | Exon 17 of 17 | NP_001394095.1 | ||
RB1 | NM_001407165.1 | c.1695+3A>C | splice_region_variant, intron_variant | Intron 17 of 26 | NP_001394094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1695+3A>C | splice_region_variant, intron_variant | Intron 17 of 26 | 1 | NM_000321.3 | ENSP00000267163.4 | |||
RB1 | ENST00000650461.1 | c.1695+3A>C | splice_region_variant, intron_variant | Intron 17 of 26 | ENSP00000497193.1 | |||||
RB1 | ENST00000643064.1 | c.192+3A>C | splice_region_variant, intron_variant | Intron 1 of 1 | ENSP00000496005.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1695+3A>C pathogenic mutation results from an A to C substitution three nucleotides after coding exon 17 of the RB1 gene. This mutation was reported in an individual with sporadic bilateral retinoblastoma (Lohmann, DR et al. Am J Hum Genet. 1996 May;58(5):940-9). This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. Based on nucleotide sequence alignment, this position is well conserved in available vertebrate species. Using the BDGP splice site prediction tool, this alteration is predicted to abolish the native donor site, while the ESEfinder splice site prediction tool predicts a weakening in the native splice donor site efficiency; however, direct evidence is unavailable. Based on the available evidence, c.1695+3A>C is classified as a pathogenic mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at